The genetic and immunopathological processes underlying collagen-induced arthritis

Immunology

Volumn 103, Issue 4, 2001, Pages 407-416

  Luross, Jeff A ^a   Williams, Neil A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN;

ANTIBODY SPECIFICITY; CELL POPULATION; CYTOKINE PRODUCTION; DISEASE MODEL; GENETIC ANALYSIS; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; MICE; T-LYMPHOCYTE SUBSETS;

EID: 0034888885     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01267.x     Document Type: Review

References (100)

1. Autoimmunity to type II collagen: An experimental model of arthritis
2. Induction of arthritis in monkeys by immunization with type II collagen
3. Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen
4. Immunisation against heterologous type II collagen induces arthritis in mice
5. Incidence of arthritis and autoreactivity of anticollagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II
6. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation
7. Type II collagen autoimmunity in animals and provocations leading to arthritis
8. Type II collagen-induced arthritis
9. Collagen arthritis in mice - An MHC linked disease
10. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
11. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
12. Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice
13. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis
14. Definition of MHC and T cell receptor contacts in the HLA-DR4-restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice
15. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression
16. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis
17. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response
18. Type II collagen induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity
19. Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies
20. Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates
21. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4
22. Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the alpha/beta T cell antigen receptor
23. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies
24. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody
25. Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-la antisera
26. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule
27. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis
28. Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis
29. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis
30. Collagen-induced arthritis, an animal model of autoimmunity
31. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule
32. Collagen-induced arthritis in B10.RIII mice (H-2r): Identification of an arthritogenic T-cell determinant
33. Identification of a cyanogen bromide fragment of porcine type II collagen capable of modulating collagen arthritis in B10.RIII (H-2r) mice
34. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse
35. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis
36. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response
37. Isolation of T cell line capable of protecting mice against collagen-induced arthritis
38. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones
39. B-cell deficient mice do not develop type II collagen-induced arthritis (CIA)
40. Induction of arthritis with monoclonal antibodies to collagen
41. Serum transfer of collagen induced arthritis in mice
42. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies
43. Collagen induced arthritis as an experimental model for rheumatoid arthritis
44. Genetic susceptibility to murine collagen II autoimmune arthritis: Proposed relationship to the IgG2 autoantibody sub-class response, complement C5, major histocompatibility complex (MHC) and nonMHC loci
45. Autoantibodies to murine type II collagen in collagen-induced arthritis. A comparison of susceptible and nonsusceptible strains
46. Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease
47. Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats
48. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis
49. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors
50. Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen
51. Appearance of different lymphoid cells in synovial tissue and in peripheral blood during the course of collagen II-induced arthritis in rats
52. Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/1pr mice
53. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis
54. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody
55. Therapeutic effects of monoclonal antibodies to alpha beta TCR but not to CD4 on collagen-induced arthritis in the rat
56. A comparative study into the mechanisms of action of anti-tumor necrosis factor α, anti-CD4, and combined anti-tumor necrosis factor α/anti-CD4 treatment in early collagen-induced arthritis
57. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody
58. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2
59. Regulatory T cells and inflammatory bowel disease
60. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
61. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
62. Role of gamma delta T cells in murine collagen-induced arthritis
63. Extrathymic differentiation of resident T cells in the joints of mice with collagen-induced arthritis
64. Oestrogen-mediated suppression of collagen-induced arthritis in rats. Studies on the role of the thymus and of peripheral CD8+ T lymphocytes
65. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis
66. T cell regulation of collagen-induced arthritis in mice. II. Immuno-modulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen
67. Mice lacking mature T and B lymphocytes develop arthritis lesions after immunization with type II collagen
68. Characterization of a spontaneously occurring arthritis in male DBA/1 mice
69. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse
70. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin
71. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis
72. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice
73. Suppression of murine collagen-induced arthritis with monoclonal anti-la antibodies and augmentation with IFN-gamma
74. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice
75. Biphasic effect of interferon-gamma in murine collagen-induced arthritis
76. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis
77. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13
78. T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis
79. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis
80. Characterization of the cytokine network at a single cell level in mice with collagen-induced arthritis using a dual color ELISPOT assay
81. Interleukin-10 inhibition of the progression of established collagen-induced arthritis
82. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis
83. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors
84. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice
85. Interferon-gamma confers resistance to experimental allergic encephalomyelitis
86. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice
87. + myeloid cells
88. Collagen-induced arthritis in DBA/1 mice: Cytokine gene activation following immunization with type II collagen
89. Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA)
90. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice
91. Rheumatoid arthritis and its animal models: The role of TNF-α and the possible absence of specific immune responses
92. Interleukin-1 potentiates the development of collagen-induced arthritis in mice
93. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta
94. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice
95. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis
96. Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response
97. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation
98. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
99. Physically damaged extracellular matrix induces TNF-alpha secretion by interacting resting CD4+ T cells and macrophages
100. Functional interactions of fibronectin and TNF alpha: A paradigm of physiological linkage between cytokines and extracellular matrix moieties